Chen investigated whether the p38-TFEB pathway promoted microglial activation by inhibiting CMA-mediated NLRP3 degradation in Parkinson’s disease, which could be a potential therapeutic strategy for PD (Chen et al., 2021; Figure 1). This evidence concerns the gene TFEB and Parkinson disease.